(9R,10R)-10-acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl 3-methylbut-2-enoate

Catalog No. :
ACLOLG112
CAS No. :
477-33-8
Molecular Formula :
C21H22O7
Molecular Weight :
386.40

IUPAC Name:(9R,10R)-10-acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl 3-methylbut-2-enoate

(9R,10R)-10-acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl 3-methylbut-2-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(9R,10R)-10-acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl 3-methylbut-2-enoate
IUPAC Name(9R,10R)-10-acetoxy-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-9-yl 3-methylbut-2-enoate
MDL No.MFCD01734126
Molecular FormulaC21H22O7
Molecular Weight386.40
SMILESCC(=O)O[C@@H]1C2=C(C=CC3=C2OC(=O)C=C3)OC(C)(C)[C@@H]1OC(=O)C=C(C)C
InChI KeyFNVCLGWRMXTDSM-WOJBJXKFSA-N
Synonym2-BUTENOIC ACID, 3-METHYL-, (9R,10R)-10-(ACETYLOXY)-9,10-DIHYDRO-8,8-DIMETHYL-2-OXO-2H,8H-BENZO(1,2-B:3,4-B')DIPYRAN-9-YL ESTER | ACon1_000430 | AKOS032962664 | UNII-H96WTV8SM2 | DTXSID00963904 | CHEBI:9019 | (+)-Samidin | Samidin, >=95% (LC/MS-ELSD) | FS
CAS No.477-33-8
PubChem CID442150

Synthetic Route by SureRoute

1. ACLOLG112 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLOLG112 route product structure diagram
    ACLOLG112477-33-8
Inquiry

2. ACLOLG112 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLOLG112 route product structure diagram
    ACLOLG112477-33-8
Inquiry

Comments (0)